Okoliegbe, Ijeoma N.Hijazi, KarolinCooper, KimIronside, CorinneGould, Ian M2021-08-132021-08-132021-08-12Okoliegbe, I N, Hijazi, K, Cooper, K, Ironside, C & Gould, I M 2021, 'Antimicrobial Synergy Testing : Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived', Antibiotics, vol. 10, no. 8, 967. https://doi.org/10.3390/antibiotics100809672079-6382https://hdl.handle.net/2164/16945Funding: This research was funded by the NHS Grampian Endowment fund, grant number EA9431, and the NHS Grampian Clinical Microbiology Fund (NHS Grampian Endowment Funds, Registered Charity Number SC017296). Acknowledgments: The authors would like to thank the laboratories and clinicians who use the Cystic Fibrosis Susceptibility Testing Service. CFASS is an adult patient-testing facility, funded by the National Services Division of the Common Services Agency of the Scottish Executive.12925226engantimicrobialsceftazidimecombination antimicrobial susceptibility testinggradient diffusionPseudomonas aeruginosasynergy testingtobramycinR MedicineRK DentistryOtherEA9431Supplementary InformationRRKJournal article10.3390/antibiotics10080967108